Overview
In recent years, China's innovations in the healthcare sector, particularly in medical devices and pharmaceuticals, have grown significantly. With its rapid advancements in innovative medical technology, China is emerging as a key player in addressing global health challenges, particularly in low- and middle-income countries (LMICs). China's medical innovations can help solve critical challenges, such as improving access to essential medicines, diagnostics, and treatment tools in low-resource settings. Many LMICs grapple with challenges such as inadequate medical infrastructure, lack of access to affordable treatments, and a growing burden of non-communicable diseases. Given the significant gaps in medical infrastructure and access in these regions, China's medical innovations present a critical opportunity for sustainable healthcare solutions.
This side event aims to bring together key stakeholders, including China's innovative medical technology companies, development partners, healthcare professionals, and policymakers, to discuss the landscape of China's medical innovations and how China's innovations in medical devices and drugs can be utilized effectively in LMICs. We aim to identify the key drivers and obstacles to adopting China's health technologies in developing contexts and global health development organizations' supporting policies and strategies by fostering dialogue among experts and industry leaders.
The side event will focus on the following key objectives:
- Showcasing China's Medical Innovations: Highlight China's advances in medical devices and pharmaceuticals tailored to the healthcare needs of LMICs. Emphasize affordable, high-quality medical solutions for low-resource settings.
- Platform for Knowledge Sharing: Provide Chinese companies with a platform to share their experiences applying these products in LMIC healthcare systems. Present diverse examples and application scenarios of successful implementations of China's medical innovations.
- Facilitating Collaboration: Explore opportunities for partnerships between China's healthcare innovators and health systems in LMICs to improve access to medical solutions. Identify investment and collaboration models to accelerate innovation adoption.
- Addressing Challenges and Opportunities in Scaling: Discuss potential obstacles and opportunities in scaling these innovations in low-resource settings. Encourage global discussions on strategies to promote sustainable, scalable medical innovations that address healthcare challenges in underserved regions.
- Engagement with Global Health Organizations: Engage with key global health development organizations, such as UNICEF, WHO, Global Fund, World Bank, and the Bill & Melinda Gates Foundation, to gain their perspectives and strategies on China's innovations and their role in promoting healthcare access in LMICs.
- Global Promotion: Hold a panel with global health organizations to examine challenges and opportunities for global scaling of China's medical innovations. Discuss strategies to overcome barriers to deploying innovations in LMICs.
This side event offers a valuable opportunity to explore the intersection of China's medical innovations and the healthcare challenges faced by developing countries. This meeting will serve as a catalyst for expanding access to innovative and affordable healthcare solutions in low-resource settings by fostering dialogue and collaboration.
To get more information : https://coming soon
Speakers
 | Margaret Chan Director-General Emeritus of the World Health Organization Founding Dean of Vanke School of Public Health at Tsinghua University |
 | Kun Tang Associate Professor Vanke School of Public Health at Tsinghua University |
 | Maike Scharp Deputy Director, Diagnostics Gates Foundation |
 | Deying Xie Deputy General Manager China Sinopharm International Corporation |
 | Zhou Songyang Founder & Chief Scientist Pluslife Biotech |
 | Gabriel Leung Executive Director, Charities and Community The Hong Kong Jockey Club |
 | Mitoha Ondo’o Ayekaba Minister Ministry of Health and Social Welfare, Equatorial Guinea |
 | Ira Ovesen Deputy Representative UNFPA China |
 | Ye Xu Senior Health Advisor Asian Development Bank |
 | Xicheng Xie Founder Edan Instrument |
 | Kristoffer Gandrup-Marino Chief of Innovation, Supply Division Product Innovation Centre, UNICEF |
Organizer
Tsinghua University Vanke School of Public Health (SPH) was newly established on April 2, 2020 in the midst of the global COVID-19 pandemic. Dr. Margaret Chan, the Former Director-General and Emeritus Director-General of the World Health Organization, is the founding dean of the School. The establishment of the School is a historic milestone for Tsinghua University, as it actively undertakes its mission to shoulder the responsibility of addressing national and global challenges, development priorities and needs. It is also a timely disciplinary response to major global public health issues.
To get more information : https://vsph.tsinghua.edu.cn/en/gywm/Overview.htm
